These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13695183)

  • 1. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(5):725-7. PubMed ID: 582968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].
    Shindo T; Yasuda Y; Taira K; Mitani N; Kanda A; Akazawa A
    Yakugaku Zasshi; 1979 Dec; 99(12):1186-200. PubMed ID: 120893
    [No Abstract]   [Full Text] [Related]  

  • 5. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].
    Taira K; Yasuda Y; Shindo T; Mitani N; Akazawa A
    Yakugaku Zasshi; 1980 Mar; 100(3):272-9. PubMed ID: 7381687
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 7. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic reagents in drug allergy: immunochemical specificity in the 1,2-diphenyl-pyrazolidinedione series.
    Kasper MF; Schneider CH; Rolli H; Angst BD; de Weck AL
    Immunobiology; 1986 Oct; 173(1):98-109. PubMed ID: 2433214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile synthesis of high specific activity 4-[1-
    Singh A; Hakk H; Lupton SJ
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):386-390. PubMed ID: 29274290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption and excretion of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in man and dog.
    Dean HG; Donovan B; Murray-Leslie C; Rylett P
    Arzneimittelforschung; 1976; 26(9):1700-4. PubMed ID: 1036704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution and excretion of 14C- and 3H-labelled 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in the rat.
    Dean HG; Donovan B; Rylett P
    Arzneimittelforschung; 1976; 26(8):1574-81. PubMed ID: 1036955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
    BEHRE R
    Arzneimittelforschung; 1958 Aug; 8(8):520-5. PubMed ID: 13584244
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies on the action of 4-butyl-1,2-diphenyl-3, 5-pyrazolidinedione on embryonal fibroblasts, blood and bone marrow cells in vitro].
    ALBRECHT M; ESCHENBACH J; KRETSCHMER V
    Arzneimittelforschung; 1960 Aug; 10():606-12. PubMed ID: 13682160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some derivatives of 1,2-diphenyl-4-butyl-3, 5-pirazolidine-dione. II].
    FRANCHI G
    Farmaco Sci; 1956; 11(10):819-22. PubMed ID: 13414852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3,5-pyrazolidinedione. 2. Practical performance of the investigations].
    ECKSTEIN M; LINDNER J; von SCHWEINITZ H
    Arzneimittelforschung; 1960 Nov; 10():902-9. PubMed ID: 13725632
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Phenylbutazone (CAS No. 50-33-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1990 Mar; 367():1-205. PubMed ID: 12692637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Comparative study of several drugs belonging to the group of the 1,2-diphenyl-3,5-diketopyrazolidines. I."].
    PICCININI F; MARAZZI-UBERTI E; LUGARESI C
    Arch Int Pharmacodyn Ther; 1961 Jun; 132():16-28. PubMed ID: 13735416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.